{"id":"W2576905928","doi":"10.1016/j.leukres.2017.01.005","title":"Current approach to the treatment of chronic myeloid leukaemia","year":2017,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Ponatinib; Hematologist; Imatinib; Intensive care medicine; Imatinib mesylate; Chronic myeloid leukaemia; Oncology; Myeloid leukemia; Immunology; Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006500986,0.0007123947,0.001539224,0.001940049,0.0002926387,0.001083486,0.0008953759,0.0009729155,0.006313186],"category_scores_gemma":[0.001250362,0.0002435301,0.000748443,0.001791444,0.0004147176,0.001060036,0.0007182156,0.00201609,0.001718417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006013996,"about_ca_system_score_gemma":0.001525146,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001638259,"about_ca_topic_score_gemma":0.003851626,"domain_scores_codex":[0.9997399,0.0000590545,0.00004637372,0.00003885214,0.00009308402,0.00002273692],"domain_scores_gemma":[0.9995186,0.0002762213,0.00007625896,0.00001117093,0.00008861054,0.00002908997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001276127,0.00007250525,0.0001059998,0.03502987,0.0001530525,0.0000771097,0.00003828053,0.0002723591,0.0006728409,0.003314202,0.02770714,0.932429],"study_design_scores_gemma":[0.00007697194,0.0001331239,0.0005468099,0.01354173,0.0004230498,0.0004860549,0.00005532223,0.00007907551,0.000213697,0.00203877,0.9823882,0.00001734018],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004030891,0.9988694,0.00005683574,0.0002364832,0.0001454132,0.000004924321,0.0000176714,0.000004088401,0.0006249769],"genre_scores_gemma":[0.0003678781,0.9988695,0.0001055008,0.0002687081,0.0001171722,0.000004491756,0.00002389671,6.620552e-7,0.0002422122],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006313186,"threshold_uncertainty_score":0.02111965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3100638100786055,"score_gpt":0.4895030462241493,"score_spread":0.1794392361455439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}